查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1927675

全球药用皮肤保养市场：依应用、皮肤状况、产品特性、通路、成分类型、国家及地区划分－产业分析、市场规模、份额及2025年至2032年预测

Medicated Skincare Market, By Application, By Skin Condition, By Product Features, By Distribution Channel, By Ingredient Type, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 380 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2024 年，药用皮肤保养市场规模将达到 780.901 亿美元，从 2025 年到 2032 年，复合年增长率将达到 4.35%。

药用皮肤保养市场涵盖经临床研发的局部外用产品，用于预防、控製或治疗痤疮、湿疹、干癣、酒糟以及真菌或细菌感染疾病等皮肤疾病。这些产品既有处方笺，也有非处方药，它们将治疗功效与日常护肤功效相结合，弥合了药品和化妆品之间的鸿沟。市场成长的驱动因素包括污染、压力和生活方式改变导致的皮肤疾病发病率上升，以及皮肤科医生和消费者对皮肤问题的日益意识提升。一个关键趋势是，含有神经酰胺、烟碱酰胺和水杨酸等活性肌肤成分的科学配方、低致敏配方正逐渐普及。然而，严格的监管核准和长期使用可能带来的副作用风险等限制因素可能会阻碍其广泛应用。同时，远距皮肤科咨询和电子商务平台的扩展为在全球扩大药用皮肤保养解决方案和个人化治疗提案的覆盖范围提供了重要机会。

药用皮肤保养市场动态

皮肤疾病增多，以及人们对治疗的认识不断提高。

痤疮、皮肤炎、色素沉着和酒糟病例的增加推动了对药用皮肤保养品的需求。消费者越来越倾向于选择经临床检验的解决方案，而非化妆品替代品，这使得处方笺级洗面乳、精华液和保湿霜广受欢迎。皮肤科医师在推荐针对性治疗方案方面发挥关键作用，这些方案旨在减少发炎和细菌滋生，并修復皮肤屏障功能。社会宣传宣传活动、数位皮肤科平台以及便利的线上咨询服务有助于提高消费者对产品的认知度。空气污染加剧、荷尔蒙失衡和生活方式压力等因素也促使人们对日常准药物护理的需求增加。这种对科学验证成分的偏好转变征兆着该品类的长期成长前景良好。例如，皮肤科医生使用的数位诊断工具 VisualDx 包含超过 45,000 张医学影像，医生在远距会诊中使用这些影像来提高对色素沉着、酒糟和其他皮肤疾病的诊断准确性。

药用皮肤保养市场：細項分析

全球市场已根据应用、皮肤状况、产品属性、通路、成分类型和地区进行了市场细分。

到2025年，痤疮治疗将成为最重要的皮肤问题，约占市场份额的42%，这主要得益于荷尔蒙性痤疮病例的增加、污染相关的皮肤问题，以及水杨酸、过氧化苯甲酰和类视色素产品的广泛使用。皮肤科医生继续推荐准药物疗法而非化妆品替代品，这进一步增强了消费者对产品的信任。抗衰老龄化产品因市场对肽类和类视色素的高需求而受到关注，而敏感肌肤产品则随着消费者对低过敏性和无香料配方的需求日益增长而扩大。例如，高德美公司公布了其含有0.3%阿达帕林和2.5%过氧化苯甲酰的凝胶的III期临床试验成功数据。经过 12 週的治疗，503 名中度至重度痤疮患者接受了治疗，与对照组（低效治疗）相比，治疗使发炎性皮损平均减少了 27 个（-68.7%），非发炎性皮损平均减少了 40 个（-68.3%）。

按用途划分，洗面乳产品仍是护肤市场中最受欢迎且最有价值的产品类别。这主要归功于消费者对经皮肤科医生测试的洗面乳、抗菌配方以及pH平衡配方的高需求。洗面乳深受消费者喜爱，因为它是治疗痤疮、油脂分泌过剩和去除死皮细胞的第一步。消费者对多步骤护肤流程的日益重视以及医生对类药物洁面产品的推荐不断增加，持续推动洁面产品的市场成长。此外，随着各大品牌推出针对色素沉淀、干燥和术后修復等需求的针对性配方，精华液和保湿霜的销售量也稳定成长。例如，理肤泉的Effaclar净肤洁面啫咖哩，其pH值为5.5，有助于维持肌肤的自然平衡。它含有锌PCA，经製造商的实证研究证实，该成分能够抑制皮脂分泌。经皮肤科医师测试，产品定位为适用于敏感和易长粉刺肌肤的温和洗面乳。

药用皮肤保养市场－区域分析

北美是护肤品的重要市场。医学科技的进步催生了更多疗效显着、副作用更少的护肤产品，使其日益受到欢迎。此外，该地区消费者对皮肤问题及相关疗法的高度关注也带动了医用护肤品需求的增长。速食的盛行也促使更多人寻求这类产品。大多数快餐，如汉堡、热狗、薯条、鸡块、奶昔和汽水，都含有精製碳水化合物、脂肪和高热量，这些都可能导致过敏反应和各种皮肤问题。根据《安全与健康》杂誌2018年12月发布的数据显示，约有37%的美国人每天都吃快餐。

美国药用皮肤保养市场－国别分析

美国在药用皮肤保养市场占据重要份额，高昂的医疗保健支出和皮肤科医生的普及推动了消费者对经临床检验的痤疮、湿疹和其他发炎性皮肤病治疗方法的需求。创新和监管核准正在推动处方药和非处方药（OTC）治疗性护肤品的成长。例如，2024年8月，FDA核准了高德美公司的Nemrubio®（nemolizumab）用于治疗中重度异位性皮肤炎，从而拓展了慢性发炎性皮肤病的治疗选择。同时，2025年7月，CeraVe推出了五款新的治疗性护肤品，包括一款婴儿湿疹舒缓产品和一款皮肤屏障修復产品，以满足消费者对皮肤科医生推荐处方药的需求。

此外，Incyte公司旗下Opzelula产品计画于2025年扩展至儿童适应症，这预示着皮肤治疗领域正朝着不分年龄的方向发展。这些进展表明，产品创新和强大的临床开发平臺正在推动美国药用皮肤保养市场的发展。

目录

第一章药用皮肤保养市场概览

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章药用皮肤保养的主要市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

第四章药用皮肤保养市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

第五章药用皮肤保养市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章药用皮肤保养市场概况

  • 药用皮肤保养市占率分析（2024 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

第七章 依应用领域药用皮肤保养市场

  • 概述
    • 细分市场占有率分析：按应用
    • 洗面乳
    • 美容精华液
    • 洗剂
    • 软膏
    • 凝胶

第八章 依皮肤状况药用皮肤保养市场

  • 概述
    • 细分市场占有率分析：依皮肤状况划分
    • 粉刺
    • 酒糟
    • 湿疹
    • 银屑病
    • 色素沉着

第九章 依产品特性分類的药用皮肤保养市场

  • 概述
    • 细分市场占有率分析：依产品特性划分
    • 低过敏性
    • 不含对羟基苯甲酸酯
    • 不致粉刺
    • 无香型
    • 无需进行动物实验

第十章 依分销管道分類的药用皮肤保养市场

  • 概述
    • 细分市场占有率分析：按分销管道划分
    • 处方药
    • 线上零售
    • 非处方药
    • 药局
    • 皮肤科诊所

第十一章 依成分类型药用皮肤保养市场

  • 概述
    • 细分市场占有率分析：依成分类型
    • 抗氧化剂
    • 保湿霜
    • 抗发炎药
    • 抗菌剂
    • 抗真菌剂

第十二章 按地区分類的药用皮肤保养市场

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十三章 主要供应商分析－药用皮肤保养产业

  • 竞争对手仪錶板
    • 竞争基准
    • 竞争定位
  • 公司简介
    • L'Oreal SA
    • Beiersdorf AG
    • Mary Kay Inc.
    • Oriflame Holding AG
    • BASF SE
    • Galderma Laboratories
    • Johnson &Johnson
    • Procter &Gamble Co.
    • Unilever Plc.
    • Neocutis
    • SkinCeuticals
    • Obagi Medical
    • Dermalogica
    • La Roche-Posay
    • Murad
    • PCA Skin
    • Others

第十四章 AnalystView 360度分析

简介目录
Product Code: ANV5932

The Medicated Skincare Market size was valued at US$ 78,090.10 Million in 2024, expanding at a CAGR of 4.35% from 2025 to 2032.

The Medicated Skincare Market includes topical products that have been clinically developed to prevent, manage, or treat dermatological conditions like acne, eczema, psoriasis, rosacea, and fungal or bacterial infections. These products, which are available as prescription and over-the-counter options, fill the gap between pharmaceuticals and cosmetics by combining therapeutic efficacy with daily skincare benefits. Rising incidences of skin disorders associated with pollution, stress, and lifestyle changes, as well as increased dermatologist and consumer awareness, are driving market growth. A key trend is the move toward science-based, gentle formulations that include active dermatological ingredients such as ceramides, niacinamide, and salicylic acid. However, constraints such as strict regulatory approvals and the risk of side effects from long-term use can limit acceptance. Meanwhile, the expansion of tele-dermatology and e-commerce platforms presents a significant opportunity, allowing for greater access to medicated skincare solutions and personalized treatment recommendations globally.

Medicated Skincare Market- Market Dynamics

Rising Dermatological Conditions and Treatment Awareness

Growing cases of acne, dermatitis, hyperpigmentation, and rosace continue to push demand for medicated skin care products. Consumers are increasingly looking for clinically validated solutions rather than cosmetic alternatives, which is driving up the popularity of prescription-grade cleansers, serums, and moisturizers. Dermatologists play an important role in recommending targeted treatments to combat inflammation, bacterial growth, and barrier repair. Social awareness campaigns, digital dermatology platforms, and easy online consultation access all help to increase product visibility. Rising pollution, hormonal imbalances, and lifestyle stress all contribute to the need for daily medicated routines. This shift toward science-backed ingredients bodes well for long-term category growth. For example, VisualDx, a digital diagnostic tool used by dermatologists, contains over 45,000 medical images that clinicians can use during remote consultations to help improve the accuracy of hyperpigmentation, rosacea, and other skin disorders.

Medicated Skincare Market- Segmentation Analysis:

The worldwide market is segmented on the basis of Application, Skin Condition, Product Features, Distribution Channel, Ingredient Type, and Region.

Ache treatment is the most important skin condition in 2025, accounting for nearly 42%, driven by rising cases of hormonal acne, pollution-related skin issues, and increased use of salicylic acid, benzoyl peroxide, and retinoid-based products. Dermatologists continued to promote medicated solutions over cosmetic alternatives, increasing product confidence. Anti-aging products gained traction due to high demand for peptides and retinoids, while sensitive skin products expanded as more consumers sought hypoallergenic and fragrance-free formulations. For example, Galderma reported successful Phase III trial data for a gel containing 0.3% adapalene and 2.5% benzoyl peroxide, in which 503 moderate-to-severe acne patients treated over 12 weeks saw mean reductions of 27 inflammatory lesions (-68.7%) and 40 non-inflammatory lesions (-68.3%), compared to lower efficacy in the vehicle group.

Based on Application, the cleanser segment is the most popular and useful application in the skincare market, owing to the high demand for dermatologically tested face washes, antibacterial formulas, and pH-balanced solutions. Cleansers were popular among consumers because they serve as the first step in the treatment of acne, excess oil, and buildup. Rising awareness of multi-step routines and increased doctor recommendations for medicated cleansing agents continued to drive growth. Serums and moisturizers have grown steadily as brands introduce targeted formulas to address pigmentation, dryness, and treatment recovery needs. For instance, La Roche-Posay's Effaclar Purifying Foaming Gel has a physiological pH of 5.5, which helps maintain the skin's natural balance. It contains zinc PCA, an ingredient that has been shown in manufacturer studies to reduce sebum production. Dermatologists have tested the product, and it is described as a non-irritating cleanser for sensitive and acne-prone skin.

Medicated Skincare Market- Geographical Insights

North America is a significant market for skincare products. The product is becoming increasingly popular as medical science and technology advance, resulting in more effective and side effect-free products. Furthermore, a large number of people in this region are more aware of skin-related issues and treatments, which leads to an increase in demand for medical skincare products. Furthermore, the adoption of fast food culture increases the number of people who need this product. Most fast-food items, such as burgers, hot dogs, french fries, nuggets, milkshakes, and sodas, contain refined carbohydrates, fats, and high calories, which cause allergic reactions and a variety of skin issues. According to data published by Safety and Health Magazine in December 2018, it is estimated that 37% of the American population consumes fast food on a daily basis.

United States Medicated Skincare Market- Country Insights

The United States accounts for a significant share of medicated skincare market, with high demand for clinically validated treatments for acne, eczema, and other inflammatory skin conditions, fueled by high healthcare spending and widespread dermatologist availability. Innovation and regulatory approvals are driving growth in both prescription and over-the-counter therapeutic skincare. For example, in August 2024, the FDA approved Galderma's Nemluvio(R) (nemolizumab) for moderate-to-severe atopic dermatitis, broadening the treatment options for chronic inflammatory skin disease. Meanwhile, in July 2025, CeraVe launched five new therapeutic skincare products, including baby eczema relief and blemish barrier solutions, in response to consumer demand for dermatologist-recommended formulas.

In addition, expanded pediatric approval for Incyte's Opzelura in 2025 demonstrates the trend toward more age-inclusive dermatological treatments. These developments demonstrate how product innovation and robust clinical pipelines are bolstering the US medicated skincare market.

Medicated Skincare Market- Competitive Landscape:

The medical skin care products market is highly competitive, with numerous global and regional players vying for market share. Leading companies in the industry are focusing on product innovation, strategic partnerships, and mergers and acquisitions to improve their market position. The emphasis on research and development is critical, as companies strive to introduce advanced formulations that provide superior efficacy and address a wide range of consumer needs. Additionally, the trend toward clean and sustainable beauty is influencing market players' strategies, with an emphasis on eco-friendly ingredients and packaging solutions to meet the increasing demand for sustainable products. Multinational corporations such as Johnson & Johnson, Procter & Gamble, L'Oreal, and Unilever dominate the market due to their extensive product portfolios and global reach. These businesses rely on their brand equity and distribution networks to maintain a competitive advantage, while also investing in marketing and promotional activities to increase brand visibility and consumer engagement.

Recent Developments:

In May 2024, Otsuka Pharmaceutical Co., Ltd. introduced InnerSignal, a new basic skincare line that includes "Repair Lotion" and "Repair Milk" to address epidermal imbalance and promote cellular turnover. The products contain high-moisturizing ingredients as well as active medicinal components like dipotassium glycyrrhizate and ectoin, which help to prevent rough skin and dullness caused by dryness and UV exposure.

In June 2024, SkinCeuticals has announced the release of P-TIOX, a clinically proven wrinkle-modulating peptide serum that reduces the appearance of expression lines and wrinkles. The serum, which combines peptides and antioxidants to improve skin smoothness and firmness, is now available from SkinCeuticals' official channels.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MEDICATED SKINCARE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • L'Oreal S.A.
  • Beiersdorf AG
  • Mary Kay Inc.
  • Oriflame Holding AG
  • BASF SE
  • Galderma Laboratories
  • Johnson & Johnson
  • Procter & Gamble Co.
  • Unilever Plc.
  • Neocutis
  • SkinCeuticals
  • Obagi Medical
  • Dermalogica
  • La Roche-Posay
  • Murad
  • PCA Skin
  • Others

GLOBAL MEDICATED SKINCARE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cleanser
  • Serums
  • Lotions
  • Ointments
  • Gels

GLOBAL MEDICATED SKINCARE MARKET, BY SKIN CONDITION- MARKET ANALYSIS, 2019 - 2032

  • Acne
  • Rosacea
  • Eczema
  • Psoriasis
  • Hyperpigmentation

GLOBAL MEDICATED SKINCARE MARKET, BY PRODUCT FEATURES- MARKET ANALYSIS, 2019 - 2032

  • Hypoallergenic
  • Paraben-free
  • Non-comedogenic
  • Fragrance-free
  • Cruelty-free

GLOBAL MEDICATED SKINCARE MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Prescription
  • Online retail
  • Over-the-counter
  • Pharmacies
  • Dermatologist clinics

GLOBAL MEDICATED SKINCARE MARKET, BY INGREDIENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Antioxidants
  • Moisturizers
  • Anti-inflammatories
  • Antibacterials
  • Antifungals

GLOBAL MEDICATED SKINCARE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Medicated Skincare Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Medicated Skincare Market Snippet by Application
    • 2.1.2. Medicated Skincare Market Snippet by Skin Condition
    • 2.1.3. Medicated Skincare Market Snippet by Product Features
    • 2.1.4. Medicated Skincare Market Snippet by Distribution Channel
    • 2.1.5. Medicated Skincare Market Snippet by Ingredient Type
    • 2.1.6. Medicated Skincare Market Snippet by Country
    • 2.1.7. Medicated Skincare Market Snippet by Region
  • 2.2. Competitive Insights

3. Medicated Skincare Key Market Trends

  • 3.1. Medicated Skincare Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Medicated Skincare Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Medicated Skincare Market Opportunities
  • 3.4. Medicated Skincare Market Future Trends

4. Medicated Skincare Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Medicated Skincare Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Medicated Skincare Market Landscape

  • 6.1. Medicated Skincare Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Medicated Skincare Market - By Application

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 7.1.2. Cleanser
    • 7.1.3. Serums
    • 7.1.4. Lotions
    • 7.1.5. Ointments
    • 7.1.6. Gels

8. Medicated Skincare Market - By Skin Condition

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Skin Condition, 2024 & 2032 (%)
    • 8.1.2. Acne
    • 8.1.3. Rosacea
    • 8.1.4. Eczema
    • 8.1.5. Psoriasis
    • 8.1.6. Hyperpigmentation

9. Medicated Skincare Market - By Product Features

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product Features, 2024 & 2032 (%)
    • 9.1.2. Hypoallergenic
    • 9.1.3. Paraben-free
    • 9.1.4. Non-comedogenic
    • 9.1.5. Fragrance-free
    • 9.1.6. Cruelty-free

10. Medicated Skincare Market - By Distribution Channel

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Skin Condition, 2024 & 2032 (%)
    • 10.1.2. Prescription
    • 10.1.3. Online retail
    • 10.1.4. Over-the-counter
    • 10.1.5. Pharmacies
    • 10.1.6. Dermatologist clinics

11. Medicated Skincare Market - By Ingredient Type

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Ingredient Type, 2024 & 2032 (%)
    • 11.1.2. Antioxidants
    • 11.1.3. Moisturizers
    • 11.1.4. Anti-inflammatories
    • 11.1.5. Antibacterials
    • 11.1.6. Antifungals

12. Medicated Skincare Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Medicated Skincare Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Medicated Skincare Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Medicated Skincare Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Medicated Skincare Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Medicated Skincare Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Medicated Skincare Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. L'Oreal S.A.
    • 13.2.2. Beiersdorf AG
    • 13.2.3. Mary Kay Inc.
    • 13.2.4. Oriflame Holding AG
    • 13.2.5. BASF SE
    • 13.2.6. Galderma Laboratories
    • 13.2.7. Johnson & Johnson
    • 13.2.8. Procter & Gamble Co.
    • 13.2.9. Unilever Plc.
    • 13.2.10. Neocutis
    • 13.2.11. SkinCeuticals
    • 13.2.12. Obagi Medical
    • 13.2.13. Dermalogica
    • 13.2.14. La Roche-Posay
    • 13.2.15. Murad
    • 13.2.16. PCA Skin
    • 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us